Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells. (Q54541508)

31 May 2018

title

Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells. (English)

1 reference

31 May 2018

1 reference

George C Liu

1

1 reference

31 May 2018

Gavin Y Oudit

2

1 reference

31 May 2018

Fei Fang

3

1 reference

31 May 2018

Joyce Zhou

4

1 reference

31 May 2018

James W Scholey

5

1 reference

31 May 2018

publication date

21 December 2011

1 reference

31 May 2018

American Journal of Physiology - Renal Physiology

published in

1 reference

31 May 2018

volume

302

1 reference

31 May 2018

issue

6

1 reference

31 May 2018

page(s)

F784-90

1 reference

31 May 2018

Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Enhanced angiotensin-converting enzyme 2 attenuates angiotensin II-induced collagen production via AT1 receptor-phosphoinositide 3-kinase-Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Inhibition by cAMP of Ras-dependent activation of Raf.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

The role of erk1 and erk2 in multiple stages of T cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Angiotensin (1-7) induces MAS receptor internalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Historical Perspective of the Renin-Angiotensin System

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

A family of cAMP-binding proteins that directly activate Rap1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Protein kinase A-independent activation of ERK and H,K-ATPase by cAMP in native kidney cells: role of Epac I

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Coupling of neuronal 5‐HT7 receptors to activation of extracellular‐regulated kinase through a protein kinase A‐independent pathway that can utilize Epac

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Human recombinant ACE2 reduces the progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Angiotensin-(1-7): an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00455.2011

10.1152/AJPRENAL.00455.2011

21 January 2018

Identifiers

DOI

1 reference

31 May 2018

PubMed ID

22189944

1 reference

31 May 2018